Sweden· SE-19831007000087
Antabus 200 mg Brustablett
A medicinal product containing disulfiram, registered in Sweden by Actavis Group PTC ehf..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Disulfiram
- Manufacturer
- Actavis Group PTC ehf.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19831007000087
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Disulfiram in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayAntabusTeva Pharmaceuticals
- FinlandAntabusTeva B.V.
- United KingdomAntabuse 200mg tabletsActavis UK Ltd
- United StatesDisulfiramGolden State Medical Supply, Inc.
- CzechiaANTABUSTeva B.V., Haarlem
- PolandAnticolZakłady Farmaceutyczne POLPHARMA S.A.
- NetherlandsAntabus dispergetten 400 mg, bruistablettenAurobindo Pharma B.V.
- IcelandAntabusTeva B.V.*
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Czechia · Antabus
- Germany · Tetraethylthiuramdisulfid Smartpractice Europe
- Denmark · Antabus
- Spain · Antabus
- Finland · Antabus
- France · Esperal
- United Kingdom (Northern Ireland) · Antabuse, Disulfiram Accord-Uk
- Hungary · Antaethyl
- Ireland · Antabuse
- Iceland · Antabus
- Italy · Antabuse Dispergettes, Etiltox
- Malta · Disural
- Netherlands · Disulfiram Aurobindo, Refusal
- Norway · Antabus
- Poland · Anticol, Disulfiram Wzf
- Portugal · Tetradin
- Romania · Antalcol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a7666ec0-1a66-4bff-a77d-66d5557cf2b0 GET /v1/drugs/a7666ec0-1a66-4bff-a77d-66d5557cf2b0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "19831007000087",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19831007000087",
"product_doc_link": "https://docetp.mpa.se/LMF/Antabus%20effervercent%20tablet%20SmPC_09001bee807a300c.pdf"
}See everything about disulfiram.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.